Senseonics (SENS) Trading Up -3.3%

Shares of Senseonics Holdings Inc (NYSEAMERICAN:SENS) were up 3.3% during mid-day trading on Wednesday . The company traded as high as $2.81 and last traded at $2.60. Approximately 200,900 shares changed hands during mid-day trading, a decline of 57% from the average daily volume of 465,414 shares. The stock had previously closed at $2.69.

Separately, Canaccord Genuity reaffirmed a “buy” rating on shares of Senseonics in a research note on Wednesday, November 1st.

The company has a market cap of $367.87 and a P/E ratio of -5.36. The company has a current ratio of 2.93, a quick ratio of 2.81 and a debt-to-equity ratio of 0.76.

Senseonics (NYSEAMERICAN:SENS) last posted its earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.13). The company had revenue of $2.10 million during the quarter, compared to analysts’ expectations of $1.51 million. Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The firm’s revenue was up 425.0% compared to the same quarter last year. research analysts anticipate that Senseonics Holdings Inc will post -0.54 EPS for the current fiscal year.

In other Senseonics news, major shareholder Peter J. Barris sold 139,645 shares of Senseonics stock in a transaction on Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Mukul Jain sold 11,885 shares of Senseonics stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $3.25, for a total transaction of $38,626.25. The disclosure for this sale can be found here. Company insiders own 34.10% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp bought a new stake in shares of Senseonics in the 3rd quarter worth about $116,000. Perceptive Advisors LLC bought a new stake in shares of Senseonics in the 3rd quarter worth about $160,000. Citadel Advisors LLC bought a new stake in shares of Senseonics in the 3rd quarter worth about $194,000. Renaissance Technologies LLC bought a new stake in shares of Senseonics in the 1st quarter worth about $111,000. Finally, Susquehanna International Group LLP bought a new stake in shares of Senseonics in the 2nd quarter worth about $155,000. Hedge funds and other institutional investors own 30.66% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Senseonics (SENS) Trading Up -3.3%” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/29/senseonics-sens-trading-up-3-3.html.

About Senseonics

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

What are top analysts saying about Senseonics? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Senseonics and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit